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T HE first attempts at clinical small intes-tine transplantation had very poor 
results.l One of the presumed reasons is that 
the role of graft-versus-host reaction 
(GVHR) induced by the small bowel graft is 
not yet fully evaluated. How far GVHR-
induced lesions (GVHRIL) become apparent 
and if they are based on lymphoid tissue 
restricted G VHR or an extralymphatic 
GVHR, too, is disputed.2 Transplantation of 
small intestine in the rat provides a useful 
model that allows answers to the following 
questions: (1) Does the quantity of grafted 
lymphatic tissue influence the strength of 
GVHR and the survival of the recipients? (2) 
What is the morphological correlation of 
GVHR in the graft? (3) Which lymphoid and 
non lymphoid organs of the recipient are 
involved in GVHR, thus becoming target 
organs of GVHR? (4) Do the characteristics 
of GVHR show a specific time course? 
MATERIALS AND METHODS 
Total or half small intestine was transplanted hetero-
topically.3 Portal vein and an aortic cuff of the graft were 
anastomosed to the inferior vena cava and the abdominal 
aorta of the recipient. The oral end of the graft was 
closed, its distal end anastomosed to the terminal ileum of 
the recipient. Half (group I, n = 15) and total (group 2, 
n = 31) small bowel of F344 rats was transplanted to 
(F344 x CAP) F I , hybrids and half (group 3, n = 30) 
and total (group 4, n = 26) small intestine of BN rats was 
grafted into (BN x LEW)F] hybrid recipients. In addi-
tion, a syngeneic control group (n = 28) was performed. 
The clinical features of the recipients after transplanta-
tion have been correlated with histomorphologic investi-
gations of the graft as well as with the lymphatic tissues 
and small bowel of the recipient. 
RESULTS 
Mortality Rates 
After syngeneic transplantation, there was 
no mortality until 120 days after operation. In 
the semiallogeneic groups, mortality with the 
clinical appearance of wasting disease was 
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found to be dependent on the quantity of 
grafted tissue. The animals developing 
GVHR disease showed progressive weight 
loss and heavy inflammatory alterations of 
the integument. Autopsy revealed striking 
diminution of adipose tissue. The recipients' 
intestines appeared transparent and puffed up 
with gas. Comparison of survival times (Fig. 
1) shows that the strength of GVHR is closely 
correlated to the quantity of lymphatic tissue 
grafted. 
Histologic Appearance of the Graft 
No morphological alterations of the me-
senteric lymph nodes of the syngeneic grafts 
were found between days 15-25 after trans-
plantation. During the same period, strong 
expression of GVHR can be found within the 
mesenteric lymph nodes of a semi allogeneic 
graft. The histologic picture shows immuno-
blasts and proliferation of epitheloid cells in 
the paracortical area (Fig. 2). All layers of 
the bowel wall of the graft, including mucosal 
epithelium, showed no morphological altera-
tions. 
GVHRIL in Recipients' Organs 
Compared with syngeneic controls, periph-
eral lymph nodes and spleen showed marked 
proliferation of immunocompetent cel1s with 
partial destruction of normal histologic archi-
tecture. The mucosal surface of the recipients' 
small bowels showed severe erosive enteritis 
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Fig. 1 . SUrvival times of recipients of semiaUo· 
geneic smaU bowel grafts after develop.ment of GVHR. 
vvith loss of the villi The lamina propria was 
infiltrated by numerous immunoblasts and 
activated lymphoid cells. 
Time Course oJGVHRlL 
All alterations showed a typical time 
dependence with maximum expression be-
tween days 15 and 25 after transplantation, 
followed by regression and fibrosis of 
lymphatic tissues. 
CONCLUSIONS 
The GVHRIL foHowing transplantation of 
small intestine are different from those found 
after bone marrow transplantation or spleen 
cell injections4•5 in that they show a remark-
a ble, significant prevalence of lesions within 
the intestinal mucosa. These findings are 
consistent with the observation that jntestinal 
lymphocytes newly formed in mesenteric 
lymph nodes predominantly home in on the 
intestine again.& The degree of histologic 
alteration within different tissues indicates 
that the graft and the host may survive the 
lesions of the lymphatic tissues, whereas the 
severe intestinal lesions following GVHR may 
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Fig. 2. Hi&tologiepicture of a mesenteric lymph 
node of the small bowel graft. (A) Syngeneic graft with 
normal appearance of the lymph node (day 15). {a} 
Immunologic stimulation in GVHR. The paracortical 
area contains numerous immunobfasts (arrows!. 
easily cause death of the recipient. With 
regard to clinical sman bowel transplantation 
two statements can be made: (l) GVHRIL 
play a significant role in small bowel trans~ 
plantation. (2) To minimize their biologic 
importance, a selective elimination of the 
graft's Jymph nodes by irradiation or surgical 
resection should be considered in view of the 
remarkable difference between GVHRIL in 
lymph nodes and in the graft's intestinal wall 
itse·lf. 
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